Patents by Inventor Soren Johnson

Soren Johnson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclin dependent kinase inhibitors and methods of use
    Patent number: 9616062
    Abstract: The presently disclosed subject matter relates to methods and compositions for protecting healthy cells from damage due to DNA damaging agents. In particular, the presently disclosed subject matter relates to the protective action of selective cyclin dependent kinase 4/6 (CDK4/6) inhibitors administered to subjects that have been exposed to or that are at risk of exposure to DNA damage.
    Type: Grant
    Filed: December 11, 2013
    Date of Patent: April 11, 2017
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Norman E. Sharpless, Patrick J. Roberts, Kwok-Kin Wong, Soren Johnson
  • CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE
    Publication number: 20140227222
    Abstract: The presently disclosed subject matter relates to methods and compositions for protecting healthy cells from damage due to DNA damaging agents. In particular, the presently disclosed subject matter relates to the protective action of selective cyclin dependent kinase 4/6 (CDK4/6) inhibitors administered to subjects that have been exposed to or that are at risk of exposure to DNA damage.
    Type: Application
    Filed: December 11, 2013
    Publication date: August 14, 2014
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: Norman E. Sharpless, Patrick J. Roberts, Kwok Wong, Yan Liu, Soren Johnson
  • CYCLIN DEPENDENT KINASE INHIBITORS AND METHODS OF USE
    Publication number: 20120100100
    Abstract: The presently disclosed subject matter relates to methods and compositions for protecting healthy cells from damage due to DNA damaging agents. In particular, the presently disclosed subject matter relates to the protective action of selective cyclin dependent kinase 4/6 (CDK4/6) inhibitors administered to subjects that have been exposed to or that are at risk of exposure to DNA damage.
    Type: Application
    Filed: May 13, 2010
    Publication date: April 26, 2012
    Inventors: Norman E. Sharpless, Patrick J. Roberts, Kwok Wong, Yan Liu, Soren Johnson
  • HEMATOPOIETIC PROTECTION AGAINST IONIZING RADIATION USING SELECTIVE CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS
    Publication number: 20110224221
    Abstract: Methods for reducing or preventing the effects of ionizing radiation in healthy cells arc provided. The methods relate to the use of selective cyclin-dependent kinase (CDK) 4/6 inhibitors to induce transient quiescence in CDK4/6 dependent cells, such as hematopoietic stem cells and/or hematopoietic progenitor cells. Radioprotection can be effected in mammals by treatment with selective CDK4/6 inhibitor compounds either before, at the same time as, or after exposure to the ionizing radiation.
    Type: Application
    Filed: October 1, 2009
    Publication date: September 15, 2011
    Inventors: Norman E. Sharpless, Chad D. Torrice, Matthew R. Ramsey, Soren Johnson, Jessica F. Bell